Latest Investment Analysis News

Echo IQ Limited reported a modest revenue increase for the half-year ended December 2025, yet its net loss widened significantly, raising questions about its path to profitability.

Butn Limited reported a 15% increase in revenue for the half year ended December 2025 but posted a significant loss after tax of $1.85 million, marking a sharp reversal from profit in the prior period.

Tungsten Mining NL has released an updated financial analysis for its Mt Mulgine project, illustrating a substantial uplift in project economics driven by record-high tungsten and precious metal spot prices. While the study remains illustrative, it highlights the potential for accelerated development amid a robust commodity market.

Magellan Investment Partners has launched the Airlie Australian Share Fund - Active ETF (AASF), offering investors a concentrated, actively managed portfolio of Australian equities with integrated ESG considerations. The fund combines liquidity via direct applications and Securities Exchange trading, targeting long-term capital growth and income.

Regis Resources’ latest exploration update reveals strong drilling results across key targets at Duketon and Tropicana, underscoring significant growth potential and resource extensions.

Pacific Current Group has confirmed key leadership appointments with Michael Clarke named Managing Director and CEO, and Ron Patel taking on the role of Acting CFO, signaling continuity and financial stewardship.

Tungsten Mining NL’s latest scoping study confirms Mt Mulgine as a globally significant critical minerals project with strong financial prospects and strategic positioning amid tightening tungsten supply.

Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.

Pathkey.AI’s TrialKey platform continues to validate its AI-driven clinical trial success predictions, with September 2025 seeing an average 43.6% share price increase across flagged biotech stocks.

New Zealand King Salmon reports a 7% revenue decline to NZD 94.5 million and a net loss of NZD 20.8 million for the first half of 2025, suspending dividends amid ongoing challenges.

Maronan Metals Limited has had its trading suspension lifted immediately following the release of its Preliminary Economic Assessment, signaling renewed market activity.

Jatcorp has officially appointed Dr Xinpeng (Sean) Li as its CEO, locking in a three-year contract that underscores a strategic focus on sustainable growth and innovation.